0

EMPLOYEES

0

AVERAGE DAILY TESTS RAN

0

AVERAGE DAILY UNEXPECTED POSITIVES

0

AVERAGE DAILY SEVERE & MAJOR DDIs IDENTIFIED

About Precision Diagnostics

Precision Diagnostics is the only U.S. laboratory to have invested in and committed to deploying the most advanced, ultra-high sensitivity LC-MS/MS technology for clinical urine and oral fluid drug testing. Our accredited laboratory’s automated processes virtually eliminate human error, ensure fast turnaround times, and permit our scientists to focus on the data that merit their attention. Our testing methodology gives clinicians a better possibility of ensuring patient compliance and improving outcomes. We also provide world-class client support and an analytics platform which delivers actionable data in a format that supports clinical decisions.

About Precision Diagnostics

Precision Diagnostics is the only U.S. laboratory to have invested in and committed to deploying the most advanced, ultra-high sensitivity LC-MS/MS technology for clinical urine and oral fluid drug testing. Our accredited laboratory’s automated processes virtually eliminate human error, ensure fast turnaround times, and permit our scientists to focus on the data that merit their attention. Our testing methodology gives clinicians a better possibility of ensuring patient compliance and improving outcomes. We also provide world-class client support and an analytics platform which delivers actionable data in a format that supports clinical decisions.

Our Mission

We instill integrity and innovation to provide insightful health information to improve patient outcomes.

hex icons 1

Our Mission

We instill integrity and innovation to provide insightful health information to improve patient outcomes.

hex icons 2

Our Story

  • October 2011

    Precision Toxicology was founded by Jason Hansen...
  • March 2013

    In March 2013, with only 13 employees, Precision received our...
  • 2015

    Discovery from our research led us to launch the NextGen...
  • June 2016

    In June 2016, the Precision Team of more than 280...
  • March 2019

    In March 2019, we launched an expanded panel for Oral...
  • January 2012

    In January 2012, President and CEO Miguel Gallego joined Precision...
  • 2014

    In 2014, we asked the question, “What should drug cutoff...
  • September 2015

    In September 2015, with 202 employees, Precision Toxicology became Precision...
  • 2017

    A targeted Sales Expansion in 2017 led by our Vice...
  • Today

    After undergoing strategic expansion for 2019, we continue to move...

Our Story

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • October 2011

    Precision Toxicology was founded by Jason Hansen in October 2011 with the goal of transforming healthcare through clinical laboratory science, while accepting and incorporating only ethical business solutions representing the highest quality standards, rooted in honesty, fairness, and transparency.

  • January 2012

    In January 2012, President and CEO Miguel Gallego joined Precision as Chief Operating Officer, working closely with Jason to develop the company’s mission, vision, and values.

  • March 2013

    In March 2013, with only 13 employees, Precision received our first Urine Drug Testing (UDT) specimens.

    Ever since, we have been committed to delivering actionable clinical data to help clinicians improve patient outcomes. As a new company, we initially used the same LC-MS/MS instruments and validated our test methods at the same cutoff levels as the leading toxicology labs in the industry.

  • 2014

    In 2014, we asked the question, “What should drug cutoff levels be if sensitivity was not limited by technology?”

    We performed a statistical analysis of more than 46,000 of the most commonly positive drugs from our panel to see if our cutoff levels were low enough to ensure a less than 1% false negative rate, statistically speaking. The results were astounding. The study determined that current industry standard cutoff levels were suboptimal for more than 30 of the most commonly tested drugs.

  • 2015

    Discovery from our research led us to launch the NextGen Precision Testing platform in 2015.

    We invested in research-grade instrumentation and deployed the most advanced ultra-high sensitivity LC-MS/MS technology for clinical urine and oral fluid drug testing. NextGen Precision Testing set a new standard by offering LC-MS/MS testing with statistically derived cutoff levels. This means we go lower, and do so reliably, without compromising quality.

  • September 2015

    In September 2015, with 202 employees, Precision Toxicology became Precision Diagnostics.

  • June 2016

    In June 2016, the Precision Team of more than 280 employees, expanded into a new 56,000 square foot campus.

    Our robotic laboratory facility was built with intelligent attention to detail, instilling the principle “form follows function” into every element. We developed the floor plans in tandem with the organization of anticipated workflow, accessibility, and expansion. Our building was designed to optimize processing, delivering the most accurate, efficient, and expedient solutions, while maintaining the highest levels of quality, safety, and compliance. Our laboratory’s distinct glass design is a physical representation of Precision’s commitment to transparency, honesty and fairness, the key measures of integrity.

  • 2017

    A targeted Sales Expansion in 2017 led by our Vice Presidents of Sales, Mike Day and Cortney Hergenroeder, grew our sales team by delivering NextGen technology and improving patient outcomes in new territories across the country.

  • March 2019

    In March 2019, we launched an expanded panel for Oral Fluid Testing, giving clinicians additional options for supervised, non-invasive medication monitoring.

  • Today

    After undergoing strategic expansion for 2019, we continue to move into new territories and grow with new employees into 2020.

    With 400+ employees and counting, Precision Diagnostics remains committed to processing every specimen through the lens of our core values: innovation, integrity, insights, and outcomes. Each sample we receive at our laboratory is a unique opportunity to help clinicians improve patient outcomes and could even save a life.

Our Leadership Team

Corporate Compliance

Precision Diagnostics is committed to fostering a culture of compliance in all aspects of our business, upholding both the letter and the spirit of the laws and regulations that govern our business. Achieving this mission requires exceptional adherence to the highest standards of professional ethics and integrity.

Precision’s company goals and objectives are aligned with promoting ethical practices for all members of Precision Diagnostics community and those who conduct business with the company. Precision’s internal controls and operating procedures are intended to detect, prevent and deter all improper activities.

We are constantly working toward the highest level of compliance through diligent monitoring, training, and maintaining effective lines of communication.

This includes providing a secure and confidential process for individuals to express concerns or report potential violations without intimidation or fear of retaliation. We require all Employees to immediately seek guidance regarding any compliance concerns or suspected violations.

Commitment to Quality

Precision Diagnostics’ Commitment to Quality has been at the forefront since our doors opened in 2013.

With leadership support for continuous improvement and quality initiatives, Precision formulates its strategic approach by integrating quality as a component to our company goals and objectives.

In addition to our compliance with federal CLIA requirements and California’s Business and Professions Code (BPC), Precision was first awarded accreditation status by the COLA in 2013. Precision continued its Commitment to Quality by acquiring CAP (College of American Pathologists) accreditation in 2016. We proudly continue to uphold our accredited status, demonstrating an effective quality program.

Corporate Compliance

Precision Diagnostics is committed to fostering a culture of compliance in all aspects of our business, upholding both the letter and the spirit of the laws and regulations that govern our business. Achieving this mission requires exceptional adherence to the highest standards of professional ethics and integrity.

Precision’s company goals and objectives are aligned with promoting ethical practices for all members of Precision Diagnostics community and those who conduct business with the company. Precision’s internal controls and operating procedures are intended to detect, prevent and deter all improper activities.

We are constantly working toward the highest level of compliance through diligent monitoring, training, and maintaining effective lines of communication.

This includes providing a secure and confidential process for individuals to express concerns or report potential violations without intimidation or fear of retaliation. We require all Employees to immediately seek guidance regarding any compliance concerns or suspected violations.

Commitment to Quality

Precision Diagnostics’ Commitment to Quality has been at the forefront since our doors opened in 2013.

With leadership support for continuous improvement and quality initiatives, Precision formulates its strategic approach by integrating quality as a component to our company goals and objectives.

In addition to our compliance with federal CLIA requirements and California’s Business and Professions Code (BPC), Precision was first awarded accreditation status by the COLA in 2013. Precision continued its Commitment to Quality by acquiring CAP (College of American Pathologists) accreditation in 2016. We proudly continue to uphold our accredited status, demonstrating an effective quality program.

Report A Concern

Mail 

Precision Diagnostics
ATTN: Compliance Department
4215 Sorrento Valley Blvd.
San Diego, CA 92121

Mail 

Precision Diagnostics
ATTN: Compliance Department
4215 Sorrento Valley Blvd.
San Diego, CA 92121